Courtney Breen
Stock Analyst at Bernstein
(0.44)
# 3,246
Out of 5,090 analysts
3
Total ratings
n/a
Success rate
-1.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Outperform | $1,100 → $1,300 | $1,010.31 | +28.67% | 1 | Nov 24, 2025 | |
| MRNA Moderna | Initiates: Market Perform | $55 | $27.70 | +98.56% | 1 | Oct 17, 2024 | |
| PFE Pfizer | Initiates: Market Perform | $32 | $26.03 | +22.94% | 1 | Oct 17, 2024 |
Eli Lilly and Company
Nov 24, 2025
Maintains: Outperform
Price Target: $1,100 → $1,300
Current: $1,010.31
Upside: +28.67%
Moderna
Oct 17, 2024
Initiates: Market Perform
Price Target: $55
Current: $27.70
Upside: +98.56%
Pfizer
Oct 17, 2024
Initiates: Market Perform
Price Target: $32
Current: $26.03
Upside: +22.94%